[Articles] Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

Di |2024-04-17T00:30:02+02:00Aprile 17th, 2024|Categorie: Coronavirus Lancet|

Our detailed breakdown of DALYs associated with a comprehensive list of pathogens on a global, regional, and country level has revealed the magnitude of the problem and helps to indicate where research funding mismatch might exist. Given the disproport...

[Articles] Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

Di |2024-04-17T00:30:02+02:00Aprile 17th, 2024|Categorie: Coronavirus Lancet|

Our detailed breakdown of DALYs associated with a comprehensive list of pathogens on a global, regional, and country level has revealed the magnitude of the problem and helps to indicate where research funding mismatch might exist. Given the disproport...

[Articles] Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021

Di |2024-04-16T00:30:02+02:00Aprile 16th, 2024|Categorie: Coronavirus Lancet|

Substantial progress has been made in reducing LRI mortality, but the burden remains high, especially in low-income and middle-income countries. During the COVID-19 pandemic, with its associated non-pharmaceutical interventions, global incident LRI cas...

[Articles] Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial

Di |2024-04-13T00:30:01+02:00Aprile 13th, 2024|Categorie: Coronavirus Lancet|

This first-in-human aerosol BCG controlled human infection model was sufficiently well tolerated. Further work will evaluate the utility of this model in assessing vaccine efficacy and identifying potential correlates of protection.

Torna in cima